Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Chronic myeloid leukemia")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 413

  • Page / 17
Export

Selection :

  • and

In vitro sensitivity of hematopoietic progenitors to Tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemiaCOLOVIC, M; SEFER, D; BOGDANOVIC, A et al.Cancer letters. 2003, Vol 195, Num 2, pp 153-159, issn 0304-3835, 7 p.Article

Chronic myeloid leukemia in a patient with chronic idiopathic thrombocytopenic purpura: Rapid response to imatinib mesylate (STI571)IMASHUKU, Shinsaku; MORIMOTO, Akira; KURIYAMA, Kikuko et al.Medical and pediatric oncology. 2003, Vol 41, Num 2, pp 159-160, issn 0098-1532, 2 p.Article

The use of isobaric tag peptide labeling (iTRAQ) and mass spectrometry to examine rare, primitive hematopoietic cells from patients with chronic myeloid leukemiaGRIFFITHS, Stephen D; BURTHEM, John; UNWIN, Richard D et al.Molecular biotechnology. 2007, Vol 36, Num 2, pp 81-89, issn 1073-6085, 9 p.Article

Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemiaVERSTOVSEK, Srdan; KANTARJIAN, Hagop; MANSHOURI, Taghi et al.Cancer. 2003, Vol 97, Num 5, pp 1248-1252, issn 0008-543X, 5 p.Article

Construction and expression of humanized chimeric T cell receptor specific for chronic myeloid leukemia cellsDONG WANG; LIJUN ZHANG; YAJUAN LI et al.Biotechnology letters. 2012, Vol 34, Num 7, pp 1193-1201, issn 0141-5492, 9 p.Article

Genomic segmental duplications on the basis of the t(9;22) rearrangement in chronic myeloid leukemiaALBANO, F; ANELLI, L; ZAGARIA, A et al.Oncogene (Basingstoke). 2010, Vol 29, Num 17, pp 2509-2516, issn 0950-9232, 8 p.Article

La leucémie myéloïde chronique en 2003 = Chronic myeloid leukemia in the year 2003LEWALLE, P; MARTIAT, P.Revue médicale de Bruxelles. 2003, Vol 24, Num 5, pp 420-430, issn 0035-3639, 11 p.Article

Megakaryocytic blast crisis as first presentation of chronic myeloid leukemiaCAMPIOTTI, L; GRANDI, A. M; BIOTTI, M. G et al.American journal of hematology. 2007, Vol 82, Num 3, pp 231-233, issn 0361-8609, 3 p.Article

Development and immunological evaluation of HLA-specific chronic myeloid leukemia polyepitope vaccine in Chinese populationWENHAO DONG; JINGRU ZHANG; NA SHAO et al.Vaccine. 2014, Vol 32, Num 28, pp 3501-3508, issn 0264-410X, 8 p.Article

Down-regulation of hematopoiesis master regulator PU.1 via aberrant methylation in chronic myeloid leukemiaHUI YANG; HUI LIANG; YAN, Jing-Song et al.International journal of hematology. 2012, Vol 96, Num 1, pp 65-73, issn 0925-5710, 9 p.Article

Response to tyrosine kinase inhibitors in chronic myeloid leukemia: experience from a west Asian developing countryMOHAMMED DHAHIR ALI; BADI, Ameer I; AL-ZEBARI, Shaima S. M et al.International journal of hematology. 2014, Vol 100, Num 3, pp 274-280, issn 0925-5710, 7 p.Article

The European Treatment and Outcome Study score is associated with clinical outcomes and treatment response following European LeukemiaNet 2013 recommendations in chronic-phase chronic myeloid leukemiaIRIYAMA, Noriyoshi; HATTA, Yoshihiro; KOBAYASHI, Sumiko et al.International journal of hematology. 2014, Vol 100, Num 4, pp 379-385, issn 0925-5710, 7 p.Article

Stem cell maintenance and disease progression in chronic myeloid leukemia : PIH: Leukemia Stem CellITO, Takahiro.International journal of hematology. 2013, Vol 98, Num 6, pp 641-647, issn 0925-5710, 7 p.Article

Splenic infarction in a child revealing chronic myeloid leukemiaDRUMMOND, David; LENOIR, Marion; PETIT, Arnaud Y et al.European journal of pediatrics. 2012, Vol 171, Num 7, pp 1141-1142, issn 0340-6199, 2 p.Article

Chronic myeloid leukemia in AsiaAU, Wing Y; CAGUIOA, Priscilla B; CHUAH, Charles et al.International journal of hematology. 2009, Vol 89, Num 1, pp 14-23, issn 0925-5710, 10 p.Article

Efficacy and safety of imatinib mesylate for patients in the first chronic phase of chronic myeloid leukemia: Results of a Japanese phase II clinical studyMORISHIMA, Yasuo; OGURA, Michinori; TAKAHASHI, Masatomo et al.International journal of hematology. 2004, Vol 80, Num 3, pp 261-266, issn 0925-5710, 6 p.Article

Toward therapeutic effects evaluation of chronic myeloid leukemia drug: Electrochemical platform for caspase-3 activity sensingSHIWEI ZHOU; TINGTING ZHENG; YANGFAN CHEN et al.Biosensors & bioelectronics. 2014, Vol 61, pp 648-654, issn 0956-5663, 7 p.Article

Clinical reagents of GM-CSF and IFN-α induce the generation of functional chronic myeloid leukemia dendritic cells in vitroKAIZHI WENG; XIAOBAO XIE; GUOQIANG QIU et al.Cytotechnology (Dordrecht). 2012, Vol 64, Num 1, pp 75-81, issn 0920-9069, 7 p.Article

Chronic myeloid leukemia presenting as vulvar hematomaSHIVKUMAR, Poonam; TAYADE, Surekha; SRUJANA, Reddy et al.International journal of gynaecology and obstetrics. 2008, Vol 101, Num 1, pp 82-83, issn 0020-7292, 2 p.Article

Intensified Inflammatory Reaction of Actinic Keratoses after Single Application of Topical 5-Fluorouracil in a Patient Treated with Nilotinib for Chronic Myeloid LeukemiaSCHMID-WENDTNER, Monika-Hildegard; WENDTNER, Clemens M.Dermatology (Basel). 2009, Vol 219, Num 4, pp 341-343, issn 1018-8665, 3 p.Article

Ectopic spleen presenting as a pelvic massPAGOTI, R; YOUNG, E; GIE, C. A et al.International journal of gynaecology and obstetrics. 2007, Vol 96, Num 1, pp 51-52, issn 0020-7292, 2 p.Article

Clinical and pathologic analysis of 16 cases of relapsed chronic myeloid leukemia after stem cell transplantationQIN HUANG; YAPING WU; SNYDER, David S et al.American journal of clinical pathology. 2007, Vol 128, Num 4, pp 565-570, issn 0002-9173, 6 p.Article

Imatinib mesylate in the treatment of chronic myelogenous leukemia : Current therapeutic approach for chronic myeloid/Myeloproliferative disorder: Focus on imatinib mesylateBORTHAKUR, Gautam; CORTES, Jorge E.International journal of hematology. 2004, Vol 79, Num 5, pp 411-419, issn 0925-5710, 9 p.Article

Molecular pathways to CML stem cells : PIH: Molecular pathogenesis of leukemia and leukemia stem cellsRICE, Kristen N; JAMIESON, Catriona H. M.International journal of hematology. 2010, Vol 91, Num 5, pp 748-752, issn 0925-5710, 5 p.Article

Diagnostic significance of detecting dysgranulopoiesis in chronic myeloid leukemiaYIN XU; DOLAN, Michelle M; NGUYEN, Phuong L et al.American journal of clinical pathology. 2003, Vol 120, Num 5, pp 778-784, issn 0002-9173, 7 p.Article

  • Page / 17